MedPath

exercise effects on cardio-renal syndrome risk factors

Not Applicable
Conditions
kidney disease.
Chronic kidney disease, stage 5
Registration Number
IRCT201106092858N5
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

kidney patients; dialysis; the ability to exercise
exclusion criteria: inability to exercise; smoking

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FGF23. Timepoint: befor and after 16 week of exercise. Method of measurement: ELISA kit.;Fetuin A. Timepoint: befor and after 16 week of exercise. Method of measurement: ELISA kit.;Crp. Timepoint: befor and after 16 week of exercise. Method of measurement: ELISA kit.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath